{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T02:47:31Z","timestamp":1782096451344,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Leading Talents Plan, Beijing Municipal Health Commission","award":["No. LJRC20240306; Beijing, China"],"award-info":[{"award-number":["No. LJRC20240306; Beijing, China"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-05909-3","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:47:18Z","timestamp":1777603638000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of cumulative systemic inflammation response index and all-cause mortality in adult with cardiovascular-kidney-metabolic syndrome stages 0\u20132: a prospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Xiaojun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongchong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"5909_CR1","doi-asserted-by":"publisher","first-page":"574111","DOI":"10.3389\/fpubh.2020.574111","volume":"8","author":"A Budreviciute","year":"2020","unstructured":"Budreviciute A, Damiati S, Sabir DK, et al. Management and Prevention Strategies for Non-communicable Diseases (NCDs) and Their Risk Factors. Front Public Health. 2020;8:574111.","journal-title":"Front Public Health"},{"issue":"21","key":"5909_CR2","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1001\/jama.2023.22276","volume":"330","author":"H Larkin","year":"2023","unstructured":"Larkin H. Here\u2019s What to Know About Cardiovascular-Kidney-Metabolic Syndrome, Newly Defined by the AHA. JAMA. 2023;330(21):2042\u20133.","journal-title":"JAMA"},{"issue":"20","key":"5909_CR3","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, et al. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association. Circulation. 2023;148(20):1606\u201335.","journal-title":"Circulation"},{"issue":"8","key":"5909_CR4","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1681\/ASN.0000000658","volume":"36","author":"Z Xie","year":"2025","unstructured":"Xie Z, Yu C, Cui Q, et al. Global Burden of the Key Components of Cardiovascular-Kidney-Metabolic Syndrome. J Am Soc Nephrol. 2025;36(8):1572\u201384.","journal-title":"J Am Soc Nephrol"},{"issue":"21","key":"5909_CR5","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1001\/jama.2024.6892","volume":"331","author":"R Aggarwal","year":"2024","unstructured":"Aggarwal R, Ostrominski JW, Vaduganathan M. Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults, 2011\u20132020. JAMA. 2024;331(21):1858\u201360.","journal-title":"JAMA"},{"issue":"20","key":"5909_CR6","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, et al. A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association. Circulation. 2023;148(20):1636\u201364.","journal-title":"Circulation"},{"key":"5909_CR7","doi-asserted-by":"publisher","first-page":"101407","DOI":"10.1016\/j.ajpc.2026.101407","volume":"25","author":"H Ding","year":"2026","unstructured":"Ding H, Jiang L, Zhao Y, Lee D, Chun B. Associations between cardiovascular-kidney-metabolic syndrome staging and risks of all-cause and cardiovascular mortality: a systematic review and meta-analysis. Am J Prev Cardiol. 2026;25:101407.","journal-title":"Am J Prev Cardiol"},{"issue":"3 Pt 1","key":"5909_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jacasi.2024.12.003","volume":"5","author":"H Zhang","year":"2025","unstructured":"Zhang H, Hu Z, Wu J, et al. Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages Among Middle-Aged and Older Adults in China. JACC Asia. 2025;5(3 Pt 1):393\u20135.","journal-title":"JACC Asia"},{"issue":"1","key":"5909_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1523-1755.2005.00398.x","volume":"68","author":"M Tonelli","year":"2005","unstructured":"Tonelli M, Sacks F, Pfeffer M, et al. Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int. 2005;68(1):237\u201345.","journal-title":"Kidney Int"},{"issue":"23","key":"5909_CR10","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","volume":"54","author":"P Libby","year":"2009","unstructured":"Libby P, Ridker PM, Hansson GK. Leducq Transatlantic Network on Atherothrombosis,. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54(23):2129\u201338.","journal-title":"J Am Coll Cardiol"},{"key":"5909_CR11","doi-asserted-by":"publisher","first-page":"176338","DOI":"10.1016\/j.ejphar.2024.176338","volume":"966","author":"A Attiq","year":"2024","unstructured":"Attiq A, Afzal S, Ahmad W, Kandeel M. Hegemony of inflammation in atherosclerosis and coronary artery disease. Eur J Pharmacol. 2024;966:176338.","journal-title":"Eur J Pharmacol"},{"issue":"7121","key":"5909_CR12","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860\u20137.","journal-title":"Nature"},{"key":"5909_CR13","doi-asserted-by":"publisher","first-page":"811790","DOI":"10.3389\/fcvm.2022.811790","volume":"9","author":"Q Li","year":"2022","unstructured":"Li Q, Ma X, Shao Q, et al. Prognostic Impact of Multiple Lymphocyte-Based Inflammatory Indices in Acute Coronary Syndrome Patients. Front Cardiovasc Med. 2022;9:811790.","journal-title":"Front Cardiovasc Med"},{"key":"5909_CR14","doi-asserted-by":"publisher","first-page":"107602962211461","DOI":"10.1177\/10760296221146183","volume":"28","author":"W Fan","year":"2022","unstructured":"Fan W, Wei C, Liu Y, et al. The Prognostic Value of Hematologic Inflammatory Markers in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Clin Appl Thromb Hemost. 2022;28:10760296221146183.","journal-title":"Clin Appl Thromb Hemost"},{"key":"5909_CR15","doi-asserted-by":"publisher","first-page":"718032","DOI":"10.3389\/fneur.2021.718032","volume":"12","author":"J Li","year":"2021","unstructured":"Li J, Yuan Y, Liao X, Yu Z, Li H, Zheng J. Prognostic Significance of Admission Systemic Inflammation Response Index in Patients With Spontaneous Intracerebral Hemorrhage: A Propensity Score Matching Analysis. Front Neurol. 2021;12:718032.","journal-title":"Front Neurol"},{"key":"5909_CR16","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.2147\/CIA.S339221","volume":"16","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Xing Z, Zhou K, Jiang S. The Predictive Role of Systemic Inflammation Response Index (SIRI) in the Prognosis of Stroke Patients. Clin Interv Aging. 2021;16:1997\u20132007.","journal-title":"Clin Interv Aging"},{"issue":"14","key":"5909_CR17","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1002\/cncr.30057","volume":"122","author":"Q Qi","year":"2016","unstructured":"Qi Q, Zhuang L, Shen Y, et al. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. Cancer. 2016;122(14):2158\u201367.","journal-title":"Cancer"},{"key":"5909_CR18","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.2147\/CMAR.S197911","volume":"11","author":"S Li","year":"2019","unstructured":"Li S, Xu H, Wang W, et al. The systemic inflammation response index predicts survival and recurrence in patients with resectable pancreatic ductal adenocarcinoma. Cancer Manag Res. 2019;11:3327\u201337.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"5909_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13098-023-01178-8","volume":"15","author":"F Kong","year":"2023","unstructured":"Kong F, Huang J, Xu C, Huang T, Wen G, Cheng W. System inflammation response index: a novel inflammatory indicator to predict all-cause and cardiovascular disease mortality in the obese population. Diabetol Metab Syndr. 2023;15(1):195.","journal-title":"Diabetol Metab Syndr"},{"key":"5909_CR20","doi-asserted-by":"publisher","first-page":"1338025","DOI":"10.3389\/fimmu.2024.1338025","volume":"15","author":"L Gu","year":"2024","unstructured":"Gu L, Xia Z, Qing B, et al. Systemic Inflammatory Response Index (SIRI) is associated with all-cause mortality and cardiovascular mortality in population with chronic kidney disease: evidence from NHANES (2001\u20132018). Front Immunol. 2024;15:1338025.","journal-title":"Front Immunol"},{"issue":"1","key":"5909_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s40001-022-00733-9","volume":"27","author":"KB Lin","year":"2022","unstructured":"Lin KB, Fan FH, Cai MQ, et al. Systemic immune inflammation index and system inflammation response index are potential biomarkers of atrial fibrillation among the patients presenting with ischemic stroke. Eur J Med Res. 2022;27(1):106.","journal-title":"Eur J Med Res"},{"issue":"17","key":"5909_CR22","doi-asserted-by":"publisher","first-page":"9553","DOI":"10.3390\/ijms23179553","volume":"23","author":"EA Dziedzic","year":"2022","unstructured":"Dziedzic EA, G\u0105sior JS, Tuzimek A, et al. Investigation of the Associations of Novel Inflammatory Biomarkers-Systemic Inflammatory Index (SII) and Systemic Inflammatory Response Index (SIRI)-With the Severity of Coronary Artery Disease and Acute Coronary Syndrome Occurrence. Int J Mol Sci. 2022;23(17):9553.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5909_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/eurjpc\/zwaa052","volume":"29","author":"Z Chen","year":"2022","unstructured":"Chen Z, Mo J, Xu J, et al. Effects of individual and integrated cumulative burden of blood pressure, glucose, low-density lipoprotein cholesterol, and C-reactive protein on cardiovascular risk. Eur J Prev Cardiol. 2022;29(1):127\u201335.","journal-title":"Eur J Prev Cardiol"},{"issue":"16","key":"5909_CR24","doi-asserted-by":"publisher","first-page":"e034996","DOI":"10.1161\/JAHA.124.034996","volume":"13","author":"J Li","year":"2024","unstructured":"Li J, Lei L, Wang W, et al. Social Risk Profile and Cardiovascular-Kidney-Metabolic Syndrome in US Adults. J Am Heart Assoc. 2024;13(16):e034996.","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"5909_CR25","doi-asserted-by":"publisher","first-page":"e2445309","DOI":"10.1001\/jamanetworkopen.2024.45309","volume":"7","author":"R Zhu","year":"2024","unstructured":"Zhu R, Wang R, He J, et al. Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages by Social Determinants of Health. JAMA Netw Open. 2024;7(11):e2445309.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"5909_CR26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ijo.2010.152","volume":"35","author":"LP Palaniappan","year":"2011","unstructured":"Palaniappan LP, Wong EC, Shin JJ, Fortmann SP, Lauderdale DS. Asian Americans have greater prevalence of metabolic syndrome despite lower body mass index. Int J Obes (Lond). 2011;35(3):393\u2013400.","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"5909_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12889-024-21131-2","volume":"25","author":"Y Cao","year":"2025","unstructured":"Cao Y, Wang W, Xie S, Xu Y, Lin Z. Joint association of the inflammatory marker and cardiovascular-kidney-metabolic syndrome stages with all-cause and cardiovascular disease mortality: a national prospective study. BMC Public Health. 2025;25(1):10.","journal-title":"BMC Public Health"},{"issue":"1","key":"5909_CR28","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1186\/s40001-025-02929-1","volume":"30","author":"Y Huang","year":"2025","unstructured":"Huang Y, Yin X, Li Z. Impact of systemic immune inflammation index and systemic inflammation response index on all-cause and cardiovascular mortality in cardiovascular-kidney-metabolic syndrome. Eur J Med Res. 2025;30(1):645.","journal-title":"Eur J Med Res"},{"issue":"1","key":"5909_CR29","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12933-025-02692-x","volume":"24","author":"Y Chen","year":"2025","unstructured":"Chen Y, Lian W, Wu L, et al. Joint association of estimated glucose disposal rate and systemic inflammation response index with mortality in cardiovascular-kidney-metabolic syndrome stage 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):147.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"5909_CR30","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1053\/j.ackd.2006.07.010","volume":"13","author":"L Chalmers","year":"2006","unstructured":"Chalmers L, Kaskel FJ, Bamgbola O. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease. Adv Chronic Kidney Dis. 2006;13(4):352\u201364.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"11","key":"5909_CR31","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1097\/01.ASN.0000141966.69934.21","volume":"15","author":"BE Wisse","year":"2004","unstructured":"Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. 2004;15(11):2792\u2013800.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"5909_CR32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0002-9343(01)01123-8","volume":"112","author":"IJ Jonkers","year":"2002","unstructured":"Jonkers IJ, Mohrschladt MF, Westendorp RG, van der Laarse A, Smelt AH. Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial. Am J Med. 2002;112(4):275\u201380.","journal-title":"Am J Med"},{"issue":"2","key":"5909_CR33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.diabres.2014.04.006","volume":"105","author":"N Esser","year":"2014","unstructured":"Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014;105(2):141\u201350.","journal-title":"Diabetes Res Clin Pract"},{"key":"5909_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1741-7015-11-117","volume":"11","author":"J Frosteg\u00e5rd","year":"2013","unstructured":"Frosteg\u00e5rd J. Immunity, atherosclerosis and cardiovascular disease. BMC Med. 2013;11:117.","journal-title":"BMC Med"},{"issue":"17\u201318","key":"5909_CR35","first-page":"1405","volume":"108","author":"SO Kolset","year":"1988","unstructured":"Kolset SO. [The role of macrophages in cancer prevention]. Tidsskr Nor Laegeforen. 1988;108(17\u201318):1405\u20138.","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"6","key":"5909_CR36","doi-asserted-by":"publisher","first-page":"H1219","DOI":"10.1152\/ajpheart.00796.2011","volume":"302","author":"K Putnam","year":"2012","unstructured":"Putnam K, Shoemaker R, Yiannikouris F, Cassis LA. The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome. Am J Physiol Heart Circ Physiol. 2012;302(6):H1219\u201330.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"10","key":"5909_CR37","first-page":"1217","volume":"52","author":"LX Shang","year":"2024","unstructured":"Shang LX, Tang BP, Hou YL. [Applications of multiple exposure data in cardiovascular longitudinal studies]. Zhonghua xin xue guan bing za zhi. 2024;52(10):1217\u201320.","journal-title":"Zhonghua xin xue guan bing za zhi"},{"issue":"5","key":"5909_CR38","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/jes.2014.58","volume":"25","author":"F de Vocht","year":"2015","unstructured":"de Vocht F, Burstyn I, Sanguanchaiyakrit N. Rethinking cumulative exposure in epidemiology, again. J Expo Sci Environ Epidemiol. 2015;25(5):467\u201373.","journal-title":"J Expo Sci Environ Epidemiol"},{"issue":"8","key":"5909_CR39","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/s43587-025-00938-7","volume":"5","author":"C Franceschi","year":"2025","unstructured":"Franceschi C, Olivieri F, Moskalev A, Ivanchenko M, Santoro A. Toward precision interventions and metrics of inflammaging. Nat Aging. 2025;5(8):1441\u201354.","journal-title":"Nat Aging"},{"key":"5909_CR40","doi-asserted-by":"publisher","first-page":"1490302","DOI":"10.3389\/fragi.2024.1490302","volume":"5","author":"MV Wrona","year":"2024","unstructured":"Wrona MV, Ghosh R, Coll K, Chun C, Yousefzadeh MJ. The 3 I\u2019s of immunity and aging: immunosenescence, inflammaging, and immune resilience. Front Aging. 2024;5:1490302.","journal-title":"Front Aging"},{"issue":"2","key":"5909_CR41","doi-asserted-by":"publisher","first-page":"104409","DOI":"10.1016\/j.numecd.2025.104409","volume":"36","author":"R Intravaia","year":"2026","unstructured":"Intravaia R, Tognola C, Maloberti A, et al. The role of inflammation in acute coronary syndrome: A systematic review on biochemical inflammatory assessment and anti-inflammatory therapies. Nutr Metab Cardiovasc Dis. 2026;36(2):104409.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"39","key":"5909_CR42","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1093\/eurheartj\/ehaf517","volume":"46","author":"JT Neumann","year":"2025","unstructured":"Neumann JT, de Lemos JA, Apple FS, Leong DP. Cardiovascular biomarkers for risk stratification in primary prevention. Eur Heart J. 2025;46(39):3823\u201343.","journal-title":"Eur Heart J"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05909-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05909-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05909-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T02:02:41Z","timestamp":1782093761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05909-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5909"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05909-3","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"19 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Tongzhou Cohort Study (ClinicalTrials.gov Identifier: NCT05156580) is an ongoing prospective cohort established by Beijing Friendship Hospital, Capital Medical University. The study was conducted in accordance with the ethical principles of the 1975 Declaration of Helsinki and received approval from the Ethics Committee of Beijing Friendship Hospital, Capital Medical University (Beijing, China) (approval no. 2021-P2-163-02).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"528"}}